This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Facebook US trial focused on Zuckerberg's privacy actions kicks off in Delaware

By Mike Swift ( July 17, 2025, 00:36 GMT | Comment) -- The actions of Facebook Chief Executive Mark Zuckerberg and the company's board as the company made privacy moves during the past decade will face extreme scrutiny in an $8 billion US trial over claims by investors that the social media giant shirked its fiduciary responsibilities to shareholders.  They investors say Facebook prioritized the interests of Zuckerberg and other senior leaders as it negotiated a privacy settlement with the Federal Trade Commission in the wake of the 2018 Cambridge Analytica privacy scandal.The question of whether Facebook prioritized Chief Executive Mark Zuckerberg and other senior leadership over the company’s fiduciary responsibility to its investors in a record $5 billion privacy settlement with the Federal Trade Commission is likely to be central to the result of a US trial that began today in Delaware....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login